Erlotinib 70771-1522
Product NDC
70771-1522- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 30, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA213065
Need to source Erlotinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Erlotinib Hydrochloride | 100 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Packaging Options(3)
30 TABLET, FILM COATED in 1 BOTTLE (70771-1522-3)
3 BLISTER PACK in 1 CARTON (70771-1522-7) / 10 TABLET, FILM COATED in 1 BLISTER PACK (70771-1522-2)
90 TABLET, FILM COATED in 1 BOTTLE (70771-1522-9)